HuGE Literature Finder
Records
1
-
28
| [Rapid Idylla™ mutational testing: Current and future theranostic applications]. Annales de pathologie 2022 1 42 (4): 329-343. Bourhis Amélie, Remoué Annabelle, Samaison Laura, Uguen Arna |
| Molecular Genetic Investigation of Digital Melanoma in Dogs. Veterinary sciences 2022 2 9 (2): . Conrad David, Kehl Alexandra, Beitzinger Christoph, Metzler Thomas, Steiger Katja, Pfarr Nicole, Fischer Konrad, Klopfleisch Robert, Aupperle-Lellbach Hei |
| Intragenic NF1 deletions in sinonasal mucosal malignant melanoma. Pigment cell & melanoma research 2021 Sep . Riobello Cristina, Casanueva Muruais Rodrigo, Suárez-Fernández Laura, García-Marín Rocío, Cabal Virginia N, Blanco-Lorenzo Verónica, Franchi Alessandro, Laco Jan, López Fernando, Llorente José Luis, Hermsen Mario |
| Identification of vital genes and pathways associated with mucosal melanoma in Chinese. Annals of diagnostic pathology 2020 Nov 50 151648. Du Mingzhan, Wang Yuhong, Gu Dongmei, Guo Lingchu |
| Mutation profile of primary subungual melanomas in Caucasians. Oncotarget 2020 Jun 11 (25): 2404-2413. Borkowska Aneta, Szumera-Cieckiewicz Anna, Spalek Mateusz, Teterycz Pawel, Czarnecka Anna, Kowalik Artur, Rutkowski Pio |
| Comparative Study of NGS Platform Ion Torrent Personal Genome Machine and Therascreen Rotor-Gene Q for the Detection of Somatic Variants in Cancer. High-throughput 2020 Feb 9 (1): . Lombardi Angela, Russo Margherita, Luce Amalia, Morgillo Floriana, Tirino Virginia, Misso Gabriella, Martinelli Erika, Troiani Teresa, Desiderio Vincenzo, Papaccio Gianpaolo, Iovino Francesco, Argenziano Giuseppe, Moscarella Elvira, Sperlongano Pasquale, Galizia Gennaro, Addeo Raffaele, Necas Alois, Necasova Andrea, Ciardiello Fortunato, Ronchi Andrea, Caraglia Michele, Grimaldi An |
| Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes. Journal for immunotherapy of cancer 2019 Oct 7 (1): 279. Isaeva O I, Sharonov G V, Serebrovskaya E O, Turchaninova M A, Zaretsky A R, Shugay M, Chudakov D |
| BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis. Pathology, research and practice 2019 Sep 152671. Min Kyueng-Whan, Choe Ji-Young, Kwon Mi Jung, Lee Hye Kyung, Kang Ho Suk, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Kim Yun Joong, Kim Nan Young, Kim Ho You |
| Genetic alterations in primary melanoma in Taiwan. The British journal of dermatology 2019 Aug . Sheen Y-S, Tan K-T, Tse K-P, Liao Y-H, Lin M-H, Chen J-S, Liau J-Y, Tseng Y-J, Lee C-H, Hong C-H, Liao J-B, Chang H-T, Chu C |
| Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing. BMC cancer 2019 Jul 19 (1): 665. Lokhandwala Parvez M, Tseng Li-Hui, Rodriguez Erika, Zheng Gang, Pallavajjalla Aparna, Gocke Christopher D, Eshleman James R, Lin Ming-Ts |
| ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas. Oncology letters 2018 Dec 16 (6): 7091-7096. Osella-Abate Simona, Mereu Elisabetta, Pellegrino Elisa, Bergaggio Elisa, Ribero Simone, Bertero Luca, Lisa Francesco, Fierro Maria Teresa, Giulio Papotti Mauro, Piva Rober |
| NF1 mutations in conjunctival melanoma. British journal of cancer 2018 Mar . Scholz S L, Cosgarea I, Süßkind D, Murali R, Möller I, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker A, Steuhl K P, Schadendorf D, Westekemper H, Griewank K |
| Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients. Cancer 2018 Mar 124 (6): 1288-1296. Schwaederle Maria, Krishnamurthy Nithya, Daniels Gregory A, Piccioni David E, Kesari Santosh, Fanta Paul T, Schwab Richard B, Patel Sandip P, Parker Barbara A, Kurzrock Razel |
| Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations. Oncotarget 2017 Jun 8 (25): 40683-40692. Cosgarea Ioana, Ugurel Selma, Sucker Antje, Livingstone Elisabeth, Zimmer Lisa, Ziemer Mirjana, Utikal Jochen, Mohr Peter, Pfeiffer Christiane, Pföhler Claudia, Hillen Uwe, Horn Susanne, Schadendorf Dirk, Griewank Klaus G, Roesch Alexand |
| SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma. Archives of pathology & laboratory medicine 2017 Apr 141 (4): 564-568. Lasota Jerzy, Kowalik Artur, Felisiak-Golabek Anna, Inaguma Shingo, Wang Zeng-Feng, Pi?ciak Liliana, Zi?ba Sebastian, P?ksa Rafa?, Kopczynski Janusz, Oko? Krzysztof, Waloszczyk Piotr, Gozdz Stanislaw, Biernat Wojciech, Miettinen Mark |
| Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. British journal of cancer 2017 Feb . Malapelle Umberto, Mayo de-Las-Casas Clara, Rocco Danilo, Garzon Monica, Pisapia Pasquale, Jordana-Ariza Nuria, Russo Maria, Sgariglia Roberta, De Luca Caterina, Pepe Francesco, Martinez-Bueno Alejandro, Morales-Espinosa Daniela, González-Cao María, Karachaliou Niki, Viteri Ramirez Santiago, Bellevicine Claudio, Molina-Vila Miguel Angel, Rosell Rafael, Troncone Giancar |
| Detection of Rare Mutations by Routine Analysis of KRAS, NRAS, and BRAF Oncogenes. Bulletin of experimental biology and medicine 2017 Jan 162 (3): 375-378. Mikhailenko D S, Efremov G D, Safronova N Yu, Strelnikov V V, Alekseev B |
| Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity. Journal of dermatological science 2016 Oct . Kaji Tatsuya, Yamasaki Osamu, Takata Minoru, Otsuka Masaki, Hamada Toshihisa, Morizane Shin, Asagoe Kenji, Yanai Hiroyuki, Hirai Yoji, Umemura Hiroshi, Iwatsuki Kei |
| Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms. European journal of cancer (Oxford, England : 1990) 2015 Dec 51 (18): 2792-9. Johnson Douglas B, Menzies Alexander M, Zimmer Lisa, Eroglu Zeynep, Ye Fei, Zhao Shilin, Rizos Helen, Sucker Antje, Scolyer Richard A, Gutzmer Ralf, Gogas Helen, Kefford Richard F, Thompson John F, Becker Jürgen C, Berking Carola, Egberts Friederike, Loquai Carmen, Goldinger Simone M, Pupo Gulietta M, Hugo Willy, Kong Xiangju, Garraway Levi A, Sosman Jeffrey A, Ribas Antoni, Lo Roger S, Long Georgina V, Schadendorf Di |
| Clinical next generation sequencing to identify actionable aberrations in a phase I program. Oncotarget 2015 Aug 6 (24): 20099-110. Boland Genevieve M, Piha-Paul Sarina A, Subbiah Vivek, Routbort Mark, Herbrich Shelley M, Baggerly Keith, Patel Keyur P, Brusco Lauren, Horombe Chacha, Naing Aung, Fu Siqing, Hong David S, Janku Filip, Johnson Amber, Broaddus Russell, Luthra Raja, Shaw Kenna, Mendelsohn John, Mills Gordon B, Meric-Bernstam Fun |
| Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. The American Journal of dermatopathology 2015 May 37 (5): 389-97. Yaman Banu, Akalin Taner, Kandilo?lu Gül? |
| BRAF mutations in non-small cell lung cancer. Translational lung cancer research 2015 Apr 4 (2): 142-8. Luk Peter P, Yu Bing, Ng Chiu Chin, Mercorella Belinda, Selinger Christina, Lum Trina, Kao Steven, O'Toole Sandra A, Cooper Wendy |
| Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations. Cancer discovery 2015 Apr 5 (4): 358-67. Ahronian Leanne G, Sennott Erin M, Van Allen Eliezer M, Wagle Nikhil, Kwak Eunice L, Faris Jason E, Godfrey Jason T, Nishimura Koki, Lynch Kerry D, Mermel Craig H, Lockerman Elizabeth L, Kalsy Anuj, Gurski Joseph M, Bahl Samira, Anderka Kristin, Green Lisa M, Lennon Niall J, Huynh Tiffany G, Mino-Kenudson Mari, Getz Gad, Dias-Santagata Dora, Iafrate A John, Engelman Jeffrey A, Garraway Levi A, Corcoran Ryan |
| Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas. Pigment cell & melanoma research 2013 Sep 26 (5): 646-53. Niu Hai-Tao, Zhou Qi-Ming, Wang Fang, Shao Qiong, Guan Yuan-Xiang, Wen Xi-Zhi, Chen Li-Zhen, Feng Qi-Sheng, Li Wei, Zeng Yi-Xin, Zhang Xiao-S |
| Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry. The Journal of molecular diagnostics : JMD 2011 Sep 13 (5): 504-13. Beadling Carol, Heinrich Michael C, Warrick Andrea, Forbes Erin M, Nelson Dylan, Justusson Emily, Levine Judith, Neff Tanaya L, Patterson Janice, Presnell Ajia, McKinley Arin, Winter Laura J, Dewey Christie, Harlow Amy, Barney Oscar, Druker Brian J, Schuff Kathryn G, Corless Christopher |
| Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15): 2046-51. Paik Paul K, Arcila Maria E, Fara Michael, Sima Camelia S, Miller Vincent A, Kris Mark G, Ladanyi Marc, Riely Gregory |
| PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. PloS one 2011 6 (7): e22769. Janku Filip, Lee J Jack, Tsimberidou Apostolia M, Hong David S, Naing Aung, Falchook Gerald S, Fu Siqing, Luthra Rajyalakshmi, Garrido-Laguna Ignacio, Kurzrock Razel |
| [ Spectrum of oncogene mutations is different in melanoma subtypes]. Molekuliarnaia biologiia 0 49 (6): 1022-9. Mazurenko N N, Tsyganova I V, Lushnikova A A, Ponkratova D A, Anurova O A, Cheremushkin E A, Mikhailova I N, Demidov And L |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: